ArthroCare Corporation, a leading name in the medical device industry, is headquartered in the United States. Founded in 1990, the company has established itself as a pioneer in minimally invasive surgical solutions, particularly in orthopaedics and sports medicine. With a strong presence across North America and Europe, ArthroCare focuses on innovative technologies that enhance surgical outcomes and patient recovery. The company’s core offerings include advanced radiofrequency devices and surgical instruments designed for arthroscopic procedures. What sets ArthroCare apart is its commitment to developing unique, effective solutions that address the specific needs of healthcare professionals and patients alike. Recognised for its contributions to the field, ArthroCare has achieved significant milestones, solidifying its position as a trusted partner in the medical community.
How does ArthroCare Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ArthroCare Corporation's score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ArthroCare Corporation, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Smith & Nephew plc, which may influence its climate commitments and reporting practices. While ArthroCare has not established its own reduction targets or climate pledges, it is important to note that emissions data and performance metrics may be cascaded from its parent company, Smith & Nephew plc. This relationship suggests that any climate initiatives or targets may align with those set by Smith & Nephew, although specific details regarding these initiatives are not provided. In the context of the medical technology industry, companies are increasingly focusing on sustainability and carbon reduction. ArthroCare's commitment to climate action may evolve as it aligns with broader industry standards and practices, particularly those adopted by its parent organisation.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 10,123,000 | 00,000,000 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 67,559,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 |
ArthroCare Corporation's Scope 3 emissions, which decreased by 48% last year and decreased by approximately 59% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 73% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ArthroCare Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.